Insight Molecular Diagnostics (IMDX) Intangibles: 2020-2025
Historic Intangibles for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to $15.0 million.
- Insight Molecular Diagnostics' Intangibles fell 73.59% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year decrease of 73.59%. This contributed to the annual value of $15.0 million for FY2024, which is 73.59% down from last year.
- Insight Molecular Diagnostics' Intangibles amounted to $15.0 million in Q3 2025, which was down 0.00% from $15.0 million recorded in Q2 2025.
- In the past 5 years, Insight Molecular Diagnostics' Intangibles ranged from a high of $95.2 million in Q2 2021 and a low of $15.0 million during Q4 2024.
- Over the past 3 years, Insight Molecular Diagnostics' median Intangibles value was $56.9 million (recorded in 2024), while the average stood at $40.2 million.
- Its Intangibles has fluctuated over the past 5 years, first spiked by 530.71% in 2021, then slumped by 73.59% in 2024.
- Over the past 5 years, Insight Molecular Diagnostics' Intangibles (Quarterly) stood at $61.9 million in 2021, then remained steady at $61.9 million in 2022, then dropped by 8.00% to $56.9 million in 2023, then plummeted by 73.59% to $15.0 million in 2024, then crashed by 73.59% to $15.0 million in 2025.
- Its Intangibles was $15.0 million in Q3 2025, compared to $15.0 million in Q2 2025 and $15.0 million in Q1 2025.